Abstract:Ethnopharmacological relevance: Pulsatilla chinensis (Bunge) Regel is a traditional Chinese herbal medicine used to treat intestinal amebiasis, malaria, vaginal trichomoniasis, and bacterial infections. Anemoside B4 (AB4), a pentacyclic triterpenoid saponin, is one of the primary bioactive substances in Pulsatilla chinensis (Bunge) Regel, and gavage administration of AB4 to animals has been demonstrated to exhibit anticancer, anti-inflammatory, and antiviral actions. However, AB4 exposure in plasma is very low after oral administration, and the biotransformation of AB4 in vivo after oral administration remains unknown. Aim of the study: The reason for conducting this research was to explore at the metabolite profile of AB4 in rats following oral administration. Additionally, we aimed to develop an appropriate extravascular formulation to increase the exposure and duration of AB4 in vivo. Materials and methods: A well-validated HPLC-QQQ-MS/MS method was used for the quantification of AB4 in plasma and was further applied to evaluate and compare the pharmacokinetic properties of AB4 dissolved in a saline solution and AB4 formulations in a rectal suppository or enteric capsule. Reliable UHPLC coupled to Q-Exactive Plus high-resolution MS was used to identify the metabolites in rat plasma, bile, urine, and faeces. Results: AB4 was extensively metabolized, and a total of 29 metabolites were identified. The primary metabolic routes included deglycosylation, oxidation, dehydrogenation, reduction, sulfation, hydration, acetylation, and glucuronidation. The pharmacokinetic comparison showed that both the rectal suppository and enteric capsule increased the exposures of AB4 and one of its active metabolites, 23-hydroxybetulinic acid (23-HA). Notably, rectal suppositories increased systemic AB4 exposure (AUC0-∞) by approximately 49 and 28 times higher than that of the AB4 saline solution and enteric capsules, respectively. The t1/2 of AB4 was extended to approximately 7 h after rectal administration compared to 2 h after oral administration. Conclusion: Overall, our study demonstrated that the mismatched exposure-response relationship of AB4 could result from extensive metabolism in the gastrointestinal and circulatory systems. Thus, a rectal suppository could be an alternative formulation of AB4 to obtain both higher and longer exposure.

Biotransformation and metabolic profile of Anemoside B4 with rat small and large intestine microflora by ultra-high performance liquid chromatography-quadrupole time of flight tandem mass spectrometry.

Pharmacokinetic and metabolite profile of orally administered anemoside B4 in rats with an improved exposure in formulations of rectal suppository

Study on Chemical Profiles and Metabolites of Allii Macrostemonis Bulbus As Well As Its Representative Steroidal Saponins in Rats by Ultra-Performance Liquid Chromatography Coupled with Quadrupole Time-of-flight Tandem Mass Spectrometry

Metabolism of Echinacoside, a Good Antioxidant, in Rats: Isolation and Identification of Its Biliary Metabolites

Identification and quantification of baicalein, wogonin, oroxylin A and their major glucuronide conjugated metabolites in rat plasma after oral administration of Radix scutellariae product.

Metabolite profiling of anhuienoside C by rat intestinal bacteria using the LC-MS metabolomic approach.

Application of a Liquid Chromatography-Tandem Mass Spectrometry Method to the Pharmacokinetics, Tissue Distribution and Excretion in the Study of Anemoside B4, a Novel Antiviral Agent Candidate, in Rats.

In vivo metabolic profiles of Bu-Zhong-Yi-Qi-Tang, a famous traditional Chinese medicine prescription, in rats by ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry

Research progress on pharmacological actions and molecular mechanisms of Anemoside B4

Biotransformation and Metabolic Profile of American Ginseng Saponins with Human Intestinal Microflora by Liquid Chromatography Quadrupole Time-of-flight Mass Spectrometry

Biotransformation and metabolic profile of Xian-Ling-Gu-Bao capsule, a traditional Chinese medicine prescription, with rat intestinal microflora by ultra performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry analysis.

Discovery of a New Anti-Inflammatory Agent from Anemoside B4 Derivatives and Its Therapeutic Effect on Colitis by Targeting Pyruvate Carboxylase

The Biotransformation of Bupleuri Radix by Human Gut Microbiota

Therapeutic potential of triterpenoid saponin anemoside B4 from Pulsatilla chinensis

Biotransformation and metabolic profile of catalpol with human intestinal microflora by ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry

Biotransformation of Timosaponin BII into Seven Characteristic Metabolites by the Gut Microbiota

Exploring the Gut Microbiota Mediated Biotransformation of Senecio scandens Buch.-Ham.: Insights from Metabolite Spectrum with UHPLC-Q-Orbitrap HRMS and Bioinformatics Analysis of Gut Microbiota Metabolites

An Integrated Approach to Characterize Intestinal Metabolites of Four Phenylethanoid Glycosides and Intestinal Microbe-Mediated Antioxidant Activity Evaluation in Vitro Using UHPLC-Q-Exactive High-Resolution Mass Spectrometry and a 1,1-Diphenyl-2-picrylhydrazyl-based Assay.

A sensitive HPLC-MS/MS method for the simultaneous determination of Anemoside B4, Anemoside A3 and 23-hydroxybetulinic acid: application to the pharmacokinetics and liver distribution of Pulsatilla chinensis saponins.

Biotransformation and in Vitro Metabolic Profile of Bioactive Extracts from a Traditional Miao-Nationality Herbal Medicine, Polygonum capitatum

Using the UPLC-ESI-Q-TOF-MS E method and intestinal bacteria for metabolite identification in the nonpolysaccharide fraction from Bletilla striata.